Literature DB >> 21115876

Vascular function and circulating progenitor cells in thromboangitis obliterans (Buerger's disease) and atherosclerosis obliterans.

Naomi Idei1, Kenji Nishioka, Junko Soga, Takayuki Hidaka, Takaki Hata, Yuichi Fujii, Noritaka Fujimura, Tatsuya Maruhashi, Shinsuke Mikami, Hiroki Teragawa, Yasuki Kihara, Kensuke Noma, Kazuaki Chayama, Yukihito Higashi.   

Abstract

Thromboangitis obliterans (TAO; Buerger's disease) and atherosclerosis obliterans (ASO) are associated with endothelial dysfunction. The purpose of this study was to evaluate the role of circulating progenitor cells (CPCs) in endothelial function in patients with TAO and ASO. We measured flow-mediated vasodilation (FMD), nitroglycerine-induced vasodilation, and circulating CPCs in 30 patients with TAO and 30 age- and sex-matched healthy subjects and in 40 patients with ASO. FMD was smaller in both the TAO group and ASO group than in the control group (6.6 ± 2.7%, 5.7 ± 3.3% versus 9.5 ± 3.1%, P<0.0001, respectively). There was no significant difference in FMD between the TAO group and ASO group. Nitroglycerine-induced vasodilation was similar in the 3 groups. The number of and migration of circulating CPCs were similar in the TAO group and control group, whereas the number of and migration of circulating CPCs were significantly lower in the ASO group than in other groups (ASO 553 ± 297/mL versus TAO 963 ± 543/mL; control 1063 ± 426/mL and ASO 36 ± 18/hpf versus TAO 62 ± 23/hpf; control 68 ± 18/hpf, P<0.0001, respectively). There was a significant relationship between the number of and migration of CPCs and FMD (r = 0.43 and r = 0.40, P<0.0001, respectively). FMD was impaired in patients with TAO as well as in patients with ASO compared to that in normal control subjects, and the number of and function of circulating CPCs were not decreased in patients with TAO. These findings may partially explain why there are differences in cardiovascular morbidity and mortality rates between patients with TAO and patients with ASO.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21115876     DOI: 10.1161/HYPERTENSIONAHA.110.163683

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

1.  Circulating angiogenic factors in patients with thromboangiitis obliterans.

Authors:  Bernd Hewing; Verena Stangl; Karl Stangl; Kathrin Enke-Melzer; Gert Baumann; Antje Ludwig
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.240

2.  Relationship between flow-mediated vasodilation and cardiovascular risk factors in a large community-based study.

Authors:  Tatsuya Maruhashi; Junko Soga; Noritaka Fujimura; Naomi Idei; Shinsuke Mikami; Yumiko Iwamoto; Masato Kajikawa; Takeshi Matsumoto; Takayuki Hidaka; Yasuki Kihara; Kazuaki Chayama; Kensuke Noma; Ayumu Nakashima; Chikara Goto; Hirofumi Tomiyama; Bonpei Takase; Akira Yamashina; Yukihito Higashi
Journal:  Heart       Date:  2013-10-23       Impact factor: 5.994

3.  Vascular Function and Intima-media Thickness of a Leg Artery in Peripheral Artery Disease: A Comparison of Buerger Disease and Atherosclerotic Peripheral Artery Disease.

Authors:  Akimichi Iwamoto; Masato Kajikawa; Tatsuya Maruhashi; Yumiko Iwamoto; Nozomu Oda; Shinji Kishimoto; Shogo Matsui; Yasuki Kihara; Kazuaki Chayama; Chikara Goto; Kensuke Noma; Yoshiki Aibara; Ayumu Nakashima; Yukihito Higashi
Journal:  J Atheroscler Thromb       Date:  2016-05-09       Impact factor: 4.928

Review 4.  Dark nights behind the white clouds - risks of tobacco smoking on human health besides the oral health and malignancy.

Authors:  Zarin Zainul
Journal:  EXCLI J       Date:  2011-05-12       Impact factor: 4.068

5.  Alpha-2-macroglobulin as a Promising Biological Marker of Endothelial Function.

Authors:  Ryo Shimomura; Tomohisa Nezu; Naohisa Hosomi; Shiro Aoki; Takamichi Sugimoto; Naoto Kinoshita; Mutsuko Araki; Tetsuya Takahashi; Hirofumi Maruyama; Masayasu Matsumoto
Journal:  J Atheroscler Thromb       Date:  2017-11-01       Impact factor: 4.928

6.  Hyperuricemia is independently associated with endothelial dysfunction in postmenopausal women but not in premenopausal women.

Authors:  Tatsuya Maruhashi; Ayumu Nakashima; Junko Soga; Noritaka Fujimura; Naomi Idei; Shinsuke Mikami; Yumiko Iwamoto; Masato Kajikawa; Takeshi Matsumoto; Takayuki Hidaka; Yasuki Kihara; Kazuaki Chayama; Chikara Goto; Kensuke Noma; Hirofumi Tomiyama; Bonpei Takase; Akira Yamashina; Yukihito Higashi
Journal:  BMJ Open       Date:  2013-11-08       Impact factor: 2.692

Review 7.  8-Hydroxy-2-Deoxyguanosine Levels and Cardiovascular Disease: A Systematic Review and Meta-Analysis of the Literature.

Authors:  Alessandro Di Minno; Linda Turnu; Benedetta Porro; Isabella Squellerio; Viviana Cavalca; Elena Tremoli; Matteo Nicola Dario Di Minno
Journal:  Antioxid Redox Signal       Date:  2016-04-01       Impact factor: 8.401

8.  Cilostazol on the expression of ICAM-1, VCAM-1 and inflammatory factors in plasma in patients with thromboangiitis obliterans.

Authors:  Fuchen Song; Bo Ji; Ting Chen
Journal:  Exp Ther Med       Date:  2018-07-11       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.